Symbol
HAE on NYSE
Investment type
Equity / Common stock, $.01 par value per share
Latest Disclosed Shares Owned
1,577,323 shares
Security Ownership %
3.1%
Shares, Excluding Options vs Price
Value, Excluding Options

Capital Research Global Investors ownership in HAEMONETICS CORP Common stock, $.01 par value per share (HAE)

04 Apr 2025 - Capital Research Global Investors has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,577,323 shares of HAEMONETICS CORP Common stock, $.01 par value per share (HAE). This represents 3.1% ownership of the company. This is the first filing by Capital Research Global Investors disclosing ownership of HAEMONETICS CORP Common stock, $.01 par value per share (HAE).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.